NCM 109 Reviewer
NCM 109 Reviewer
NCM 109 Reviewer
3. Rh Sensitization
B. SOCIOECONOMIC STATUS 4. Antepartal bleeding: placenta previa and
1. Inadequate finances abruptio placenta
10. Malignancy
BLOOD TYPING (including Rh factor)
11. Major emotional disorders, mental
retardation Blood type is documented: may have to be
made available if a woman has bleeding
during pregnancy; detect the possibility of
Rh isoimmunization.
F. HABITS/HABITUATION
1. Smoking during pregnancy
MATERNAL SERUM FOR ALPHA-
2. Regular alcohol intake
FETOPROTEIN (AFP) (MSAFP)
3. Drug use/abuse
Elevated if a neural tube/abdominal defect
is present in the fetus; decreased if a
chromosomal anomaly is present.
LABORATORY ASSESSMENT
Done at 16 to 18 weeks pregnancy.
COMPLETE BLOOD COUNT The level in serum is expressed as
“multiples of the mean” (MOM).
Including hemoglobin/hematocrit + red cell
index (determine the presence of anemia), a Normal value = 2.5 MOM. If elevated or
white blood cell counts (determine infection), decreased, ultrasound/amniocentesis will
and a platelet count (estimate clotting ability). be ordered to assess for a fetal disorder.
GENETIC SCREEN
INDIRECT COOMBS’ TEST
e.g., blood sample taken to screen for sickle
Determination if Rh antibodies are present in a
cell trait; glucose-6-phosphate dehydrogenase
Rh-negative woman).
(G6PD).
Generally repeated at 28 weeks of pregnancy.
Asian and Mediterranean (beta-Thalassemia)
If the titers not elevated, Rh-negative woman
Jewish ancestry (Tay-Sachs disease)
would receive RhIG (RhoGAM) at 28 weeks of
Caucasian (cystic fibrosis) pregnancy and after any procedure that might
cause placental bleeding, such as amniocentesis
or external version.
ANTIBODY TITERS FOR RUBELLA AND IV. PREGESTATIONAL
HEPATITIS B (HBsAg)
CONDITIONS
Determine whether a woman is: protected 70 SLIDES
against rubella; newborn will have a chance of
developing hepatitis B. V. GESTATIONAL CONDITIONS
106 SLIDES
HBsAg testing may repeat at about 36 weeks.
6. Pregnancy-Induced Hypertension